Anxa1 — Annexin A1 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
ANXA1 (Annexin A1), also known as lipocortin-1, is a calcium-dependent phospholipid-binding protein belonging to the annexin family. Originally discovered as a glucocorticoid-regulated protein with anti-inflammatory properties, ANXA1 has emerged as a critical regulator of neuroinflammation, neuronal survival, and glial cell function. Its expression in the central nervous system makes it a key player in neurodegenerative disease pathogenesis and a potential therapeutic target.
The ANXA1 gene is located on chromosome 9q21.13 and consists of 13 exons encoding a protein of 346 amino acids. The gene promoter contains responsive elements for glucocorticoids, NF-κB, and other transcription factors, allowing dynamic regulation in response to inflammatory signals.
ANXA1 performs diverse cellular functions:
ANXA1 is widely expressed in the nervous system:
| Cell Type | Expression Level |
|---|---|
| Neurons | High |
| Astrocytes | High |
| Microglia | High |
| Oligodendrocytes | Moderate |
| Endothelial Cells | High |
In the brain, ANXA1 is particularly abundant in the hippocampus, cortex, and basal ganglia, regions affected in neurodegenerative diseases.
ANXA1 plays complex roles in AD:
ANXA1 is a key regulator of neuroinflammation:
ANXA1 acts through:
ANXA1-targeting strategies include:
| Model | Findings |
|---|---|
| ANXA1 Knockout Mice | Exaggerated inflammation, increased disease severity |
| Transgenic ANXA1 | Reduced neuroinflammation, neuroprotection |
| FPR2/ALX Knockout | Loss of ANXA1 anti-inflammatory effects |
| Stroke Models | ANXA1 reduces infarct size 40-60% |
The study of Anxa1 — Annexin A1 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] Gerke V, et al. Annexins: from structure to function. Biol Chem. 2002;383(7-8):1065-1080.
[2] Lim LH, et al. Annexin 1: therapeutic potential in inflammation and cancer. Trends Pharmacol Sci. 2007;28(2):86-92.
[3] Buckingham JC, et al. Annexin 1: a key regulator of the immune and neuroendocrine systems. J Endocrinol. 2009;203(1):1-12.
[4] D'Acunto CW, et al. Annexin A1 in the nervous system. Neurosci Lett. 2020;716:134682.
[5] Yazdi AS, et al. Role of annexins in neurodegeneration. Cell Mol Neurobiol. 2021;41(5):905-915.